Celldex Therapeutics’ $150 Million Common Stock Offering

Ambrogio Visconti North America, North America Legal Chronicle

Lowenstein Sandler represented issuer Celldex Therapeutics, Inc. in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) completed a $150 million public offering of common stock underwritten…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Ambrogio Visconti

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here